InDevR is a biotechnology company based in Boulder, Colorado, specialized in developing and manufacturing innovative microarray technologies and applications to support the life sciences industry. Founded in 2003, the company has received a $9.00M Series B investment led by Adjuvant Capital and bioMerieux on 17 January 2023. Their focus on biotechnology, healthcare, and manufacturing industries reinforces their commitment to advancing the life sciences field. InDevR's dedication to empowering the industry with novel solutions highlights its potential for growth and impact in the competitive market.
InDevR, Inc.
InDevR is a global leader in progressive new analytical technologies for vaccines and other biotherapeutics.
Founded 2003
Boulder, United States
25 employees
Series B
Total: $19.00M
Biotechnology, Health Care +2
Boulder, United States
25 employees
Series B
Total: $19.00M
Biotechnology, Health Care +2
General Information
Company Name
InDevR, Inc.
Founded Year
2003
Location
Boulder, United States
Boulder, United States
Founders / Decision Makers
Employees
25
Industries
Biotechnology, Health Care, Life Sciences +1
Funding Stage
Series B
BounceWatch is an independent company data service, not affiliated with InDevR, Inc.. To contact InDevR, Inc., visit indevr.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Biotechnology
About InDevR, Inc.
Taxonomy: Microarray Technologies, Life Sciences Industry, Innovative Solutions, Boulder, Colorado, Biotech, Research and Development, Medical Technology, Molecular Diagnostics, Genomics, Bioinformatics
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | $9.00M | 2 |
|
17 Jan 2023 |
| Series A | $7.00M | 1 |
|
10 Sep 2019 |
| Grant | Undisclosed | 1 |
Colorado Office of Economic Development and International Trade
|
18 Oct 2011 |
| Grant | $3.00M | 1 |
National Institute of Allergy and Infectious Diseases
|
11 Mar 2011 |
InDevR, Inc. Alternatives & Competitors
View All Alternatives
InDevR, Inc. vs
DNA/RNA Extraction kits, Chemiluminescence Substrates for Wester blotting & Fluorescent Reagents for...
Grant
18 employees
Biotechnology, Life Sciences
InDevR, Inc. vs
InDevR, Inc. vs
Centrillion Technology, Inc.
United States
Centrillion’s goal is to provide DNA chips that can map biological molecules at sub-cellular level i...
Corporate Round
53 employees
Biotechnology, Life Sciences
FAQ About InDevR, Inc.
InDevR is a global leader in progressive new analytical technologies for vaccines and other biotherapeutics.
InDevR, Inc. was founded in 2003.
InDevR, Inc. is headquartered in Boulder, United States.
InDevR, Inc. operates in Biotechnology, Health Care, Life Sciences and Manufacturing. Its work centres on Microarray Technologies, Life Sciences Industry, Innovative Solutions and Boulder, Colorado.
InDevR, Inc. has approximately 25 employees.
InDevR, Inc. has completed 4 funding rounds, raising a total of $19.00M. The latest funding stage is Series B.
Top alternatives and competitors to InDevR, Inc. include CYANAGEN S.R.L., ATCG India, Centrillion Technology, Inc., CapitalBio Technology, Thermo Fisher Scientific. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
InDevR, Inc. and CYANAGEN S.R.L. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for InDevR, Inc., https://bouncewatch.com/company/indevr, updated 30 December 2024. When citing, please name BounceWatch and link this page.
